Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1992-12-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0923-2494
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
774-6
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:1439155-Antibodies, Monoclonal,
pubmed-meshheading:1439155-Cell Division,
pubmed-meshheading:1439155-Humans,
pubmed-meshheading:1439155-Interleukin-6,
pubmed-meshheading:1439155-Multiple Myeloma,
pubmed-meshheading:1439155-Receptors, Immunologic,
pubmed-meshheading:1439155-Receptors, Interleukin-6
|
pubmed:year |
1992
|
pubmed:articleTitle |
Clinical applications of IL6 inhibitors.
|
pubmed:affiliation |
Laboratoire d'Oncogenèse immunohématologique, Institut de Biologie, Nantes, France.
|
pubmed:publicationType |
Journal Article,
Review
|